Peter Fromen

Peter Fromen has an extensive work experience spanning over two decades. Peter started their career at Howard Capital Management (Howardcapital.com) in 1998 as a Sr. Equity Analyst & Associate Portfolio Manager. Peter then moved to Agilent Technologies in 2002 where they served as an Associate Director - Investor Relations and Sr. Financial Analyst - Worldwide & Japan Field Operations. In 2005, they joined APPLIED BIOSYSTEMS as a Director - Investor Relations. Peter then joined Illumina in 2007, where they held various roles, including Global Vice President - Population Genomics & Precision Health, Global Vice President - Population Genomics, Managing Director - Population Sequencing Initiatives, Senior Director - Head of Product Marketing & Management - Life Sciences Business Unit, Senior Director - Market Development & Product Marketing - Genomics Solutions Business Unit, Senior Director - Product Marketing Applications, Services & Automation, and Senior Director - Investor Relations. In 2021, they joined Pacific Biosciences as Chief Commercial Officer (CCO), based in London. Here, they transformed the commercial organization, leading the global commercial team to achieve record levels of sales, growing revenue by 65% and more than doubling the company’s installed base of sequencers. Most recently, in 2022, Peter joined Cambridge Epigenetix as Chief Executive Officer.

Peter Fromen attended Kenyon College from 1993 to 1997, where they earned a Bachelor of Arts in History and a Concentration in Environmental Science. In 2001, they obtained a Master of Business Administration from the W. P. Carey School of Business at Arizona State University, with a focus in Financial Management & Markets.